MS Poetsch, A Strano, K Guan - Stem Cells, 2022 - academic.oup.com
The potential of human induced pluripotent stem cells (iPSCs) to self-renew indefinitely and to differentiate virtually into any cell type in unlimited quantities makes them attractive for in …
KC Sonntag, B Song, N Lee, JH Jung, Y Cha… - Progress in …, 2018 - Elsevier
Parkinson's disease (PD) is one of the most common neurodegenerative disorders, which affects about 0.3% of the general population. As the population in the developed world ages …
E Kuijk, M Jager, B van der Roest, MD Locati… - Nature …, 2020 - nature.com
Genetic changes acquired during in vitro culture pose a risk for the successful application of stem cells in regenerative medicine. To assess the genetic risks induced by culturing, we …
Induced pluripotent stem cells (iPSC) technology has propelled the field of stem cells biology, providing new cells to explore the molecular mechanisms of pluripotency, cancer …
The use of induced Pluripotent Stem Cells (iPSC) as a source of autologous tissues shows great promise in regenerative medicine. Nevertheless, several major challenges remain to …
To understand the mutational burden of human induced pluripotent stem cells (iPSCs), we sequenced genomes of 18 fibroblast-derived iPSC lines and identified different classes of …
Abstract In 2006, Shinya Yamanaka generated induced pluripotent stem cells (iPSCs), which has been the major scientific event of the decade that caught the eye of many …
S Yang, Y Cho, J Jang - BMB reports, 2021 - ncbi.nlm.nih.gov
Human pluripotent stem cells (hPSCs) include human embryonic stem cells (hESCs) derived from blastocysts and human induced pluripotent stem cells (hiPSCs) generated from …
Induced pluripotent stem cells (iPSCs) offer huge promise and potential in the creation of patient-specific stem cells for modeling human diseases, drug development and testing, and …